Skip to content
Recall Observatory FDA recall evidence

Drug product

chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01

D-0309-2025

March 11, 2025

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 95658
Status
Ongoing
Classification
Class II
Quantity
8160 bottles
Official record key
drug-enforcement:D-0309-2025

Official wording

Reason: CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Code information: Lot#s: 17232222 and 17232237, Exp 10/31/2025

Distribution pattern: Nationwide in the USA and PR

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso-Desmethyl Chlorpromazine impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP deviations